22nd Century Group Inc (XXII)

[Atlanta1]

$XXII conclusion from SA author:

Conclusion


At this point Wall Street doesn't understand 22nd Century Group's potential monopoly on a good part of the reduced risk cigarette market, or the smoking cessation market. Nor do investors yet realize the significance of the British American Tobacco licensing deal and the FDA's anticipation of 22nd Century submitting a modified risk application. 22nd Century is addressing a $700 billion market, and even if the company only achieves 1% penetration, investors would still realize at least a 20X return. From my perspective, the company's profitability, healthy balance sheet and valuable IP portfolio makes this an ideal asymmetrical trade, huge upside potential, with very little downside risk.


http://seekingalpha.com/article/1849101-22nd-century-is-worth-twice-todays-shareprice